Vascular Solutions (VASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Sales | 19,516 | 18,189 | 18,222 | 17,228 | 17,166 |
| Cost of Goods | 6,510 | 5,947 | 6,219 | 5,718 | 5,765 |
| Gross Profit | 13,006 | 12,242 | 12,003 | 11,510 | 11,401 |
| Operating Expenses | 11,080 | 7,609 | 9,994 | 10,050 | 9,919 |
| Operating Income | 2,436 | 5,580 | 2,228 | 2,178 | 2,247 |
| Interest Expense | 5 | 5 | 9 | 9 | 11 |
| Other Income | -25 | -13 | -2 | 8 | 21 |
| Pre-tax Income | 2,406 | 5,562 | 2,217 | 2,177 | 2,257 |
| Income Tax | 931 | 2,096 | 594 | 746 | 871 |
| Net Income Continuous | 1,475 | 3,466 | 1,623 | 1,431 | 1,386 |
| Net Income | $1,475 | $3,466 | $1,623 | $1,431 | $1,386 |
| EPS Basic Total Ops | 0.09 | 0.21 | 0.10 | 0.09 | 0.09 |
| EPS Basic Continuous Ops | 0.09 | 0.21 | 0.10 | 0.09 | 0.09 |
| EPS Diluted Total Ops | 0.09 | 0.21 | 0.09 | 0.09 | 0.09 |
| EPS Diluted Continuous Ops | 0.09 | 0.21 | 0.10 | 0.09 | 0.09 |
| EBITDA(a) | $2,907 | $5,968 | $2,604 | $2,536 | $2,594 |